belumosudil
Showing 1 - 10 of 10
Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)
Not yet recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- Rituximab
-
Atlanta, GeorgiaNorthside Hospital
Sep 21, 2023
Lung Transplant Rejection Trial in Petah-Tikva (Belumosudil, Azithromycin, Placebo)
Recruiting
- Lung Transplant Rejection
- Belumosudil
- +2 more
-
Petah-Tikva, IsraelInvestigational Site Number :3760001
Oct 13, 2023
Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)
Completed
- Immune System Disorder (Healthy Volunteers)
- Belumosudil
- +3 more
-
Miami, FloridaInvestigational Site Number: 8400001
Apr 11, 2023
Chronic GVHD Trial in United States (drug, procedure, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Tampa, Florida
- +4 more
Aug 10, 2023
Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)
Recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Duarte, CaliforniaCity of Hope Site Number : 8400001
Nov 23, 2023
Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,
Not yet recruiting
- Bronchiolitis Obliterans Syndrome
- +3 more
- Belumosudil
- +4 more
-
Boston, Massachusetts
- +3 more
Jun 27, 2023
Chronic GVHD Trial (Belumosudil)
Not yet recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- (no location specified)
Jan 5, 2023
Diffuse Cutaneous Systemic Sclerosis Trial in United States (Belumosudil)
Completed
- Diffuse Cutaneous Systemic Sclerosis
- Belumosudil
-
Los Angeles, California
- +4 more
Jan 5, 2023
Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)
Completed
- Drug-drug Interaction
- +2 more
- Belumosudil
- +4 more
-
Ruddington, Nottingham, United KingdomQuotient Sciences Ltd
May 9, 2022
Psoriasis Vulgaris Trial in Irvine (Belumosudil)
Completed
- Psoriasis Vulgaris
- Belumosudil
-
Irvine, CaliforniaUC Irvine Health, Dept of Dermatology
Mar 15, 2022